Cm Management, LLC Cytosorbents Corp Transaction History

Cm Management, LLC

$107 Million
Q3 2025

A detailed history of Cm Management, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Cm Management, LLC holds 1,288,128 shares of CTSO stock, worth $901,689. This represents 1.12% of its overall portfolio holdings.

Number of Shares

1,288,128

Previous 1,250,000 3.05%

Holding current value

$901,689

Previous $1.6 Million 25.19%

% of portfolio

1.12%

Previous 1.64%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$0.84 - $1.28 $32,027 - $48,803	38,128 Added 3.05%	1,288,128 $1.2 Million
Q2 2025 Aug 12, 2025	BUY	$0.81 - $1.28 $239,698 - $378,782	295,924 Added 31.02%	1,250,000 $1.6 Million
Q1 2025 May 09, 2025	BUY	$0.89 - $1.3 $226,127 - $330,298	254,076 Added 36.3%	954,076 $954,000
Q4 2024 Feb 07, 2025	SELL	$0.74 - $1.35 $74,000 - $135,000	-100,000 Reduced 12.5%	700,000 $630,000
Q3 2024 Nov 12, 2024	SELL	$0.7 - $1.55 $35,000 - $77,500	-50,000 Reduced 5.88%	800,000 $1.2 Million

Q2 2024 Aug 01, 2024	BUY	$0.7 - $1.01 $17,500 - $25,250	25,000 Added 3.03%	850,000 $595,000
Q1 2024 May 14, 2024	BUY	$0.86 - $1.07 $352,600 - $438,700	410,000 Added 98.8%	825,000 $783,000
Q4 2023 Feb 12, 2024	SELL	$1.08 - $1.94 $37,800 - $67,900	-35,000 Reduced 7.78%	415,000 $460,000
Q1 2023 May 08, 2023	SELL	$1.79 - $4.17 $44,750 - $104,250	-25,000 Reduced 5.26%	450,000 $1.52 Million
Q4 2022 Feb 09, 2023	SELL	$1.03 - $2.03 $206,000 - $405,999	-200,000 Reduced 29.63%	475,000 $736,000
Q3 2022 Nov 04, 2022	BUY	$1.2 - $2.46 $90,000 - $184,500	75,000 Added 12.5%	675,000 $918,000
Q2 2022 Aug 08, 2022	BUY	$1.76 - $3.22 $440,000 - $805,000	250,000 Added 71.43%	600,000 $1.31 Million
Q1 2022 May 09, 2022	BUY	$2.88 - $4.23 $144,000 - $211,500	50,000 Added 16.67%	350,000 $1.12 Million
Q4 2021 Feb 02, 2022	BUY	$4.05 - $8.11 $506,250 - $1.01 Million	125,000 Added 71.43%	300,000 $1.26 Million
Q3 2021 Nov 08, 2021	BUY	$7.0 - $9.71 $175,000 - $242,750	25,000 Added 16.67%	175,000 $1.42 Million
Q2 2021 Aug 10, 2021	BUY	$7.55 - $9.42 $226,500 - $282,600	30,000 Added 25.0%	150,000 $1.13 Million
Q1 2021 May 12, 2021	BUY	$8.23 - $11.48 $987,600 - $1.38 Million	120,000 New	120,000 $1.04 Million

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.8M

Call Options Held

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $30.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cm Management, LLC with notifications on news.

Account

Cm Management, LLC Cytosorbents Corp Transaction History